389 related articles for article (PubMed ID: 19969622)
1. Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction.
Sumida A; Horiba M; Ishiguro H; Takenaka H; Ueda N; Ooboshi H; Opthof T; Kadomatsu K; Kodama I
Cardiovasc Res; 2010 Apr; 86(1):113-21. PubMed ID: 19969622
[TBL] [Abstract][Full Text] [Related]
2. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of integrin-linked kinase attenuates left ventricular remodeling and improves cardiac function after myocardial infarction.
Ding L; Dong L; Chen X; Zhang L; Xu X; Ferro A; Xu B
Circulation; 2009 Sep; 120(9):764-73. PubMed ID: 19687354
[TBL] [Abstract][Full Text] [Related]
4. Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction.
Smith RS; Agata J; Xia CF; Chao L; Chao J
Life Sci; 2005 Apr; 76(21):2457-71. PubMed ID: 15763077
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway.
Tang J; Wang J; Kong X; Yang J; Guo L; Zheng F; Zhang L; Huang Y; Wan Y
Exp Cell Res; 2009 Dec; 315(20):3521-31. PubMed ID: 19800880
[TBL] [Abstract][Full Text] [Related]
6. Myocardial angiogenesis after plasmid or adenoviral VEGF-A(165) gene transfer in rat myocardial infarction model.
Hao X; Månsson-Broberg A; Grinnemo KH; Siddiqui AJ; Dellgren G; Brodin LA; Sylvén C
Cardiovasc Res; 2007 Feb; 73(3):481-7. PubMed ID: 17134685
[TBL] [Abstract][Full Text] [Related]
7. Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis.
Kobayashi H; Yasuda S; Bao N; Iwasa M; Kawamura I; Yamada Y; Yamaki T; Sumi S; Ushikoshi H; Nishigaki K; Takemura G; Fujiwara T; Fujiwara H; Minatoguchi S
J Cardiovasc Pharmacol; 2009 Dec; 54(6):510-9. PubMed ID: 19755919
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis.
Wang Y; Ahmad N; Wani MA; Ashraf M
J Mol Cell Cardiol; 2004 Nov; 37(5):1041-52. PubMed ID: 15522281
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.
Tang J; Xie Q; Pan G; Wang J; Wang M
Eur J Cardiothorac Surg; 2006 Aug; 30(2):353-61. PubMed ID: 16829080
[TBL] [Abstract][Full Text] [Related]
10. S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction.
Pleger ST; Remppis A; Heidt B; Völkers M; Chuprun JK; Kuhn M; Zhou RH; Gao E; Szabo G; Weichenhan D; Müller OJ; Eckhart AD; Katus HA; Koch WJ; Most P
Mol Ther; 2005 Dec; 12(6):1120-9. PubMed ID: 16168714
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice.
Shiomi T; Tsutsui H; Matsusaka H; Murakami K; Hayashidani S; Ikeuchi M; Wen J; Kubota T; Utsumi H; Takeshita A
Circulation; 2004 Feb; 109(4):544-9. PubMed ID: 14744974
[TBL] [Abstract][Full Text] [Related]
12. Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy.
Jayasankar V; Pirolli TJ; Bish LT; Berry MF; Burdick J; Grand T; Woo YJ
J Mol Cell Cardiol; 2004 Apr; 36(4):531-8. PubMed ID: 15081312
[TBL] [Abstract][Full Text] [Related]
13. Intramyocardial BNP gene delivery improves cardiac function through distinct context-dependent mechanisms.
Moilanen AM; Rysä J; Mustonen E; Serpi R; Aro J; Tokola H; Leskinen H; Manninen A; Levijoki J; Vuolteenaho O; Ruskoaho H
Circ Heart Fail; 2011 Jul; 4(4):483-95. PubMed ID: 21558448
[TBL] [Abstract][Full Text] [Related]
14. Midkine prevents ventricular remodeling and improves long-term survival after myocardial infarction.
Takenaka H; Horiba M; Ishiguro H; Sumida A; Hojo M; Usui A; Akita T; Sakuma S; Ueda Y; Kodama I; Kadomatsu K
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H462-9. PubMed ID: 19060126
[TBL] [Abstract][Full Text] [Related]
15. Cellular FLICE-inhibitory protein protects against cardiac remodelling after myocardial infarction.
Xiao J; Moon M; Yan L; Nian M; Zhang Y; Liu C; Lu J; Guan H; Chen M; Jiang D; Jiang H; Liu PP; Li H
Basic Res Cardiol; 2012 Jan; 107(1):239. PubMed ID: 22202974
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
Yoshiyama M; Nakamura Y; Omura T; Izumi Y; Matsumoto R; Oda S; Takeuchi K; Kim S; Iwao H; Yoshikawa J
Heart; 2005 Aug; 91(8):1080-5. PubMed ID: 16020603
[TBL] [Abstract][Full Text] [Related]
17. Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway.
Zhu M; Feng J; Lucchinetti E; Fischer G; Xu L; Pedrazzini T; Schaub MC; Zaugg M
Cardiovasc Res; 2006 Oct; 72(1):152-62. PubMed ID: 16901477
[TBL] [Abstract][Full Text] [Related]
18. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice.
Li Y; Takemura G; Kosai K; Yuge K; Nagano S; Esaki M; Goto K; Takahashi T; Hayakawa K; Koda M; Kawase Y; Maruyama R; Okada H; Minatoguchi S; Mizuguchi H; Fujiwara T; Fujiwara H
Circulation; 2003 May; 107(19):2499-506. PubMed ID: 12695295
[TBL] [Abstract][Full Text] [Related]
19. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction.
Hayashidani S; Tsutsui H; Shiomi T; Ikeuchi M; Matsusaka H; Suematsu N; Wen J; Egashira K; Takeshita A
Circulation; 2003 Oct; 108(17):2134-40. PubMed ID: 14517168
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression with an interleukin-2 fusion protein leads to improved LV function in experimental ischemic cardiomyopathy.
Koch M; Savvatis K; Scheeler M; Dhayat S; Bonaventura K; Pohl T; Riad A; Bulfone-Paus S; Schultheiss HP; Tschöpe C
Int Immunopharmacol; 2010 Feb; 10(2):207-12. PubMed ID: 19897056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
